Plasma protein risk scores for mild cognitive impairment and Alzheimer's disease in the Framingham heart study.
Saved in:
| Title: | Plasma protein risk scores for mild cognitive impairment and Alzheimer's disease in the Framingham heart study. |
|---|---|
| Authors: | Rehman H; Departments of Medicine (Biomedical Genetics), Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA., Ang TFA; Departments of Anatomy & Neurobiology, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.; Departments of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA., Tao Q; Departments of Pharmacology & Experimental Therapeutics, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA., Au R; Departments of Medicine (Biomedical Genetics), Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.; Departments of Anatomy & Neurobiology, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.; Departments of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.; Departments of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, USA.; Framingham Heart Study, Boston University School of Medicine, Framingham, Massachusetts, USA.; Alzheimer's Disease Research Center, Boston University School of Medicine, Boston, Massachusetts, USA., Farrer LA; Departments of Medicine (Biomedical Genetics), Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.; Departments of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.; Departments of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, USA.; Framingham Heart Study, Boston University School of Medicine, Framingham, Massachusetts, USA.; Alzheimer's Disease Research Center, Boston University School of Medicine, Boston, Massachusetts, USA.; Departments of Ophthalmology, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.; Departments of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA., Qiu WQ; Departments of Pharmacology & Experimental Therapeutics, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.; Alzheimer's Disease Research Center, Boston University School of Medicine, Boston, Massachusetts, USA.; Departments of Psychiatry, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA., Zhang X; Departments of Medicine (Biomedical Genetics), Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.; Framingham Heart Study, Boston University School of Medicine, Framingham, Massachusetts, USA.; Departments of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA. |
| Corporate Authors: | Alzheimer's Disease Neuroimaging Initiative |
| Source: | Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2025 Mar; Vol. 21 (3), pp. e70066. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons, Ltd Country of Publication: United States NLM ID: 101231978 Publication Model: Print Cited Medium: Internet ISSN: 1552-5279 (Electronic) Linking ISSN: 15525260 NLM ISO Abbreviation: Alzheimers Dement Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1552-5279 |
|---|---|
| DOI: | 10.1002/alz.70066 |
